Discovery of the allosteric inhibitor from actinomyces metabolites to target EGFRCSTMLR mutant protein: molecular modeling and free energy approach
Abstract EGFR (epidermal growth factor receptor), a surface protein on the cell, belongs to the tyrosine kinase family, responsible for cell growth and proliferation. Overexpression or mutation in the EGFR gene leads to various types of cancer, i.e., non-small cell lung cancer, breast, and pancreati...
Main Authors: | Ravi Saini, Sonali Kumari, Aditi Bhatnagar, Amit Singh, Abha Mishra |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-33065-7 |
Similar Items
-
Noncontiguous finished genome sequences and descriptions of Actinomyces ihuae, Actinomyces bouchesdurhonensis, Actinomyces urinae, Actinomyces marseillensis, Actinomyces mediterranea and Actinomyces oralis sp. nov. identified by culturomics
by: M.D. Mbogning Fonkou, et al.
Published: (2018-09-01) -
Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers
by: Masthan Thamim, et al.
Published: (2023-03-01) -
Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding
by: Michael J. McCarthy, et al.
Published: (2019-02-01) -
Discovery of Selective Inhibitor Leads by Targeting an Allosteric Site in Insulin-Regulated Aminopeptidase
by: Ioannis Temponeras, et al.
Published: (2021-06-01) -
Actinomyces in Tonsillectomy Materials
by: Özlem Ceren Güni̇zi̇, et al.
Published: (2020-10-01)